Bessemer Group’s iRadimed IRMD Stock Holding History

Bessemer Group’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$358K	Sell	3,717 -557	-13%	-$55.7K	﹤0.01%	1234
2025 Q4	$416K	Sell	4,274 -50	-1%	-$4.29K	﹤0.01%	1190
2025 Q3	$308K	Sell	4,324 -29	-0.7%	-$1.93K	﹤0.01%	1013
2025 Q2	$260K	Buy	4,353 +58	+1%	+$3.18K	﹤0.01%	1036
2025 Q1	$225K	Buy	4,295 +152	+4%	+$8.54K	﹤0.01%	1052
2024 Q4	$228K	Buy	4,143 +362	+10%	+$19.1K	﹤0.01%	1045
2024 Q3	$190K	Hold	3,781	–	–	﹤0.01%	1130
2024 Q2	$166K	Sell	3,781 -382	-9%	-$16.2K	﹤0.01%	1046
2024 Q1	$183K	Buy	+4,163	New	+$184K	﹤0.01%	1037

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bessemer Group's IRMD Position: Q1 2026 in Review

Bessemer Group reduced its iRadimed (IRMD) stake by 13% in Q1 2026, selling an estimated $55.7K and leaving 3,717 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #1234.

Bessemer Group first reported a position in IRMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $416K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Bessemer Group held 3,717 shares of iRadimed worth $358K as of Q1 2026.
Bessemer Group sold 557 iRadimed shares in Q1 2026, an estimated $55.7K.
iRadimed made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #1234 holding.
Bessemer Group first reported a position in iRadimed in Q1 2024 and has held it in 9 quarters since.
Bessemer Group's iRadimed position peaked at $416K in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.